Question 3: how do you decide whether to use LBA or hybrid LBA/LC–MS assays in discovery and development?
Browsing: Ask the Experts
Both LBA and LC–MS have their place in drug discovery and development. What is the advantage of using them as complimentary tools?
Question 2: both LBA and LC–MS have their place in drug discovery and development. What is the advantage of using them as complimentary tools?
Question 1: could you briefly introduce yourself and your organization?
In this ‘Ask the Experts’ feature, we will be revisiting a previous Spotlight to investigate where we are now with hybrid LBA/LC–MS and what the future may hold for the technique.
In this ‘Ask the Experts’ feature, we will be discussing the subject of outsourcing in…
Find out what Kevin Vernarec (QPS) thinks about how outsourcing might change in the future in this expert interview.
Find out what Song Li (Frontage) has to say about the future of bioanalytical outsourcing, in this video interview.
To address questions raised in our Quantitative HRMS Spotlight and to investigate how the field has progressed over the last two years, key figures from pharma, CROs, biotech and academia share with us their experiences and thoughts on HRMS, giving our members a 360° opinion series.
Read time: 3:45 mins
Find out what molecules our experts predominantly work with, and how or why they use HRMS for their analysis.
Read time: 2:30 mins
Find out what type of analyses our experts use HRMS for and why.